The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Erri, S. and Oroszi, T. (2025) Isolated Systolic Hypertension in Geriatrics. International Journal of Clinical Medicine, 16, ...

The researchers found that people taking alpha-1 blockers – terazosin, doxazosin, and alfuzosin – were around 40% less likely to develop DLB than people taking other prostate drugs ...

The alpha blocker is typically prescribed to manage a nuisance symptom. Here's why the FDA says patients and healthcare ...

Certain drugs can cause low blood pressure as a side effect. These include: All blood pressure medications, including beta blockers, alpha-blockers ... reducing sensitivity to glucagon-like peptide-1 ...

RESULTS Seventy nine patients were identified (seven dead, 72 transplanted). Two patients (2.5%) were heterozygous for the Z allele of α 1-AT and four (5.1%) were heterozygous for the S allele. This ...

As Medicare announced a fresh set of drugs selected for its price-setting process on Friday under the Inflation Reduction Act, industry group PhRMA criticized the landmark legislation, arguing ...

However, drugmakers whose treatments are granted accelerated approval are required to conduct postmarketing trials to confirm the drug's benefit ... Seeking Alpha has reached out to Sarepta ...

Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...

The government had until Feb. 1 to announce the next batch of drugs. And it had to use data that ran through Jan. 15 in making its drug selections. Friday's announcement comes a few weeks before ...